390459
Framework for Risk Assessment of Plastic Additives
390459
390376
2025 Annual Report
390376
390161
Repeat Dose Toxicity testing workshop: From concept to application
390161
390163
Planetary boundary for novel entities
390163
390494
We’re Hiring: Join the ECETOC Team as a Trainee!
390494
390456
ECETOC publishes a framework for the risk assessment of plastic additives
390456
2016-06-01 04:09:13
Epigenetics – Roland Buesen
387859
See the video
HSSD Tool
389215
The Human Exposure Assessment Tools Database (heatDB)
389219
NanoApp
389220
Targeted Risk Assessment (TRA)
389221
TRA Task Force – Worker branch
390482
Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]
390465
Chronic fish case studies towards an IATA
390155
Overview of ECETOC
Structure & Governance
Our Members
Secretariat
Contact us
What we do
Areas of work
Task Forces
Events
Our work structure
Resources
Tools
Publications
Latest News
Media
Get Involved
Become a Member
a
Overview of ECETOC
Structure & Governance
Our Members
Secretariat
Contact us
What we do
Areas of work
Task Forces
Events
Our work structure
Resources
Tools
Publications
Latest News
Media
Get Involved
Become a Member
NGRA and NAMs
Related Topics
Adverse Outcome Pathways (AOPs)
Exposure-led assessment
In vitro models
Integrated testing strategies
Mapped:Next Generation Risk Assessment
Next Generation Risk Assessment
Non-animal testing
Quantitative Structure-Activity Relationships
Read-across
Read-across (implied in species extrapolation)
Regulatory validation
Threshold of Toxicological Concern (TTC)
Toxicokinetics
Toxicological Concern (TTC)
Publications
378236
Workshop Report no.40 – Chronos and Kairos: Understanding time in biology for NGRA
378236
378217
Considerations for the development of guidance on dose level selection for developmental and reproductive toxicity studies
378217
378213
Workshop Report no.38 – Exploring best practices in quantitative AOPs (qAOPs)
378213
378168
Heterogeneity in biological assemblages and exposure in chemical risk assessment: Exploring capabilities and challenges in methodology with two landscape-scale case studies
378168
378165
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro‑to‑in vivo extrapolation (IVIVE) in chemical risk assessment
378165
378197
Recommendations on dose level selection for repeat dose toxicity studies
378197
378133
Creating sets of similar nanoforms with the ECETOC NanoApp: real-life case studies
378133
378132
Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny – part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?
378132
378116
TR 138 – ECETOC Guidance on Dose Selection
378116
View all related publications
Task Forces
Chronic fish case studies towards an IATA
390155
Good Practices in Omics Data Interpretation for Regulatory Applications
387832
Staged assessment: Exemplify the staged assessment process by using it to provide more information in low tonnage bands
387802
Smart studies: Examine how in vivo studies could provide more information encompassing novel studies (and endpoints)
387801
Use of clinical data in identification of respiratory sensitisers
387799
Dose Selection Task Force
387793
View all completed task forces
News
ECETOC is hiring a new administrative assistant
375524
375528
ECETOC Activity Update
375528
375526
An update from the Secretary General
375526
![Immunotoxicity assessment: Addressing Challenges and Advancing Methodologies [Workshop → Task Force]](https://www.ecetoc.org/wp-content/uploads/2026/07/Picture2-1024x923.jpg)
